跳至主要内容
临床试验/NCT05600101
NCT05600101已完成不适用

Development of Avatar-based Intervention to Support Patients Undergoing Reduced-Intensity Allogenic Stem Cell Transplantation

Dana-Farber Cancer Institute2 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2022年12月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
18
试验地点
2
主要终点
Number of Participants Retained

研究概览

简要总结

The goal of this research study is to provide an avatar-based technology during a subject's stay for participants who have been admitted to the hospital for reduced-intensity conditioning (RIC) allogeneic transplant. The intervention received will be the care.coach technology.

详细描述

This research study is a Pilot Study, which means the investigators are studying the application in a smaller group of people to understand whether the technology, care.coach, is easy to use.

This is a single site study at Dana-Farber Brigham and Women's Cancer Center.

  • Aim 1 of the study will be an 8 - 10 participant focus group of nurses, navigator nurses, physicians, and NPs/PAs to refine the avatar protocols.

  • Aim 2 of the study will be a pilot of 18 participants undergoing RIC allogeneic HCT in the hospital.

  • The research study procedures include screening for eligibility, a brief call with a research assistant during use of care.coach avatar, and a survey after study completion.

  • The avatar is designed to communicate with participants regarding transplantation education and provide reminders for eating, drinking, and activity.

  • care.coach is a digital, avatar-based technology that communicates using natural speech software.

  • care.coach is supporting this research by providing Dana-Farber access to its technology. The National Cancer Institute (NCI) also supports this research.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •for HCT focus group:
  • •DFCI/HCC HCT nurse navigators, inpatient HCT nurses, and HCT physicians and extenders (NP/PA).
  • •Inclusion Criteria for care.coach pilot:
  • •Admitted for reduced-intensity conditioning (RIC) allogeneic HCT

排除标准

  • •for care.coach pilot:
  • •Deemed by clinical staff or RA to be unable to converse with an avatar, due to:
  • •Severe, uncorrectable hearing impairment and simultaneous severe, uncorrectable vision impairment.
  • •Severe speech impairment that precludes understanding by staff (and by extension, by the avatar).
  • •Not fluent in English.

研究组 & 干预措施

care.coach Pilot

Experimental

The research study procedures include screening for eligibility, a brief call with a research assistant after tablet is given to subject, and a survey after a subject has completed the study.

  • 3 consecutive cohorts of 6 RIC HCT patients each.
  • care.coach is a "human-in the-loop" conversational agent (avatar) used to interact and converse with patients through natural dialogue and text-to-speech software that is powered by a team of trained human staff, called health advocates. A subject uses the avatar for up to 3 weeks.

干预措施: Care.Coach (Behavioral)

结局指标

主要结局

Number of Participants Retained

时间窗: Baseline to 3 weeks

Participants complete study protocol, including post-completion survey, from enrollment to hospital discharge or 3 weeks from enrollment (whichever is earlier).

次要结局

  • Final Cohort Dissatisfaction Rate(3 weeks)
  • The Completion Rate Post-Pilot Survey(3 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gregory A. Abel, MD

Principal Investigator

Dana-Farber Cancer Institute

研究点 (2)

Loading locations...

相似试验